|
Volumn 36, Issue 1, 2001, Pages 181-184
|
Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BRAIN DERIVED NEUROTROPHIC FACTOR;
CEP 751;
MESSENGER RNA;
ANTINEOPLASTIC ACTIVITY;
CANCER GRAFT;
CANCER INHIBITION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG MECHANISM;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
NEUROBLASTOMA;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
QUANTITATIVE ASSAY;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TUMOR GROWTH;
XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BRAIN-DERIVED NEUROTROPHIC FACTOR;
CARBAZOLES;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
IN SITU NICK-END LABELING;
MICE;
MICE, NUDE;
NEOPLASM PROTEINS;
NEUROBLASTOMA;
PHOSPHORYLATION;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
RECEPTOR, TRKB;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
TRANSFECTION;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035165355
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/1096-911X(20010101)36:1<181::AID-MPO1043>3.0.CO;2-Q Document Type: Conference Paper |
Times cited : (56)
|
References (5)
|